Reevaluating Eligibility Criteria — Balancing Patient Protection and Participation in Oncology Trials

Abstract

Specific patient populations are often excluded from oncology trials without clear reasons, which renders results less clearly applicable to all patients. A more logical approach would be to study safety in a broad population and modify criteria as knowledge emerges.